Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05670847
PHASE2/PHASE3
Exogenous Ketone Esters for Drug Resistant Epilepsy
Sponsor: Sohag University
View on ClinicalTrials.gov
Summary
This study aims to investigate the efficacy of add-on exogenous ketone esters for treating children with drug-resistant epilepsy
Official title: Efficacy of Ketone Esters for Children With Drug Resistant Epilepsy
Key Details
Gender
All
Age Range
1 Year - 16 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-01-10
Completion Date
2025-07-01
Last Updated
2024-11-27
Healthy Volunteers
No
Conditions
Interventions
DRUG
Exogenous ketone ester
500 mg/kg orally three times daily (with at least 4 hours between each dose) for 28 days
Locations (1)
Department of Pediatrics at Sohag University Hospital
Sohag, Egypt